The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Fractionated Stereotactic Radiosurgery for Large Brain Metastases
Official Title: PHASE I STUDY OF FRACTIONATED STEREOTACTIC RADIOSURGERY FOR LARGE BRAIN METASTASES
Study ID: NCT02054689
Brief Summary: This is a research trial that seeks to break up the total radiation dose into multiple smaller radiation treatments, termed fractionated stereotactic radiosurgery (FSRS) which may make the treatment feasible. Fractionated sterotatcic radiation, the risks of FSRS, and possible costs will be described later in this document. This clinical trial is for people who have had no prior whole brain radiation.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
UPMC Shadyside Radiation Oncology, Pittsburgh, Pennsylvania, United States
Name: Steve Burton, MD
Affiliation: University of Pittsburgh
Role: PRINCIPAL_INVESTIGATOR